<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Haloperidol Pharmacology: Mechanism of Action, Therapeutic Uses & Adverse Effects</title>
  <meta name="description" content="Haloperidol pharmacology, mechanism of action, therapeutic uses, adverse effects, antipsychotic" />
  <link rel="stylesheet" href="style.css">
</head>
<body>

  <header class="site-header">
    <div class="container">
      <div class="logo">
        <a href="index.html">Dr M Medical Courses</a>
      </div>
      <nav class="main-nav">
        <ul>
          <li><a href="index.html">Home</a></li>
          <li><a href="pharmacology.html">Pharmacology Courses</a></li>
          <li><a href="about.html">About</a></li>
        </ul>
      </nav>
    </div>
  </header>

  <main>
    <header>
      <h1>Haloperidol Pharmacology: Mechanism of Action, Therapeutic Uses & Adverse Effects</h1>
    </header>

    <section>
      <h2>Overview</h2>
      <ul>
        <li>Famous trade name is Haldol</li>
        <li>It is classified as high potency typical antipsychotic drug from butyrophenones family</li>
        <li>Used in treatment of schizophrenia and some other mental disorders</li>
        <li>Haloperidol was discovered in 1958 by the Belgian physician Paul Janssen</li>
      </ul>
    </section>

    <section>
      <h2>Pharmacokinetics</h2>
      <ul>
        <li>Available as oral, IM and IV formulas</li>
        <li>Good absorption of oral formula with bioavailability of 60-70%</li>
        <li>Distribution: haloperidol is heavily protein bound by 90%, free part distributed to different body tissues</li>
        <li>Metabolized by the liver through glucuronidation and CYP oxidation by CYP3A4</li>
        <li>Excreted through bile and urine</li>
      </ul>
    </section>

    <section>
      <h2>Mechanism of action</h2>
      <ul>
        <li>Haloperidol work by antagonizing dopamine D2 receptors in the brain</li>
        <li>It blocks dopamine in the mesolimbic and mesocortical pathway which lead to relieving the psychotic symptoms</li>
        <li>It also blocks dopamine in the nigrostriatal pathway which lead to extrapyramidal symptoms as adverse effects</li>
        <li>It also blocks dopamine in the tuberoinfundibular pathway lead to hyperprolactinemia as an adverse effect</li>
        <li>Haloperidol also has anti serotonin, antimuscarinic and anti histamine activity</li>
        <li>It blocks alpha adrenergic receptors to some degree too</li>
      </ul>
    </section>

    <section>
      <h2>Therapeutic uses</h2>
      <ul>
        <li>Psychotic disorders like schizophrenia and acute psychosis</li>
        <li>Tics in Tourette syndrome</li>
        <li>Manic phase of bipolar disorder</li>
        <li>Agitation and aggressive behavior</li>
        <li>Alcohol withdrawal</li>
        <li>Treatment of intractable hiccups</li>
        <li>Severe nausea and vomiting not responding to first line medications</li>
      </ul>
    </section>

    <section>
      <h2>Dosing</h2>
      <ul>
        <li>For schizophrenia and Tourette syndrome: dose is 0.5 to 2 mg orally 2 to 3 times a day, max dose is 30 mg/day</li>
        <li>For acute agitation: 2 to 5 mg intramuscular every 4 to 8 hours</li>
      </ul>
    </section>

    <section>
      <h2>Treatment considerations</h2>
      <ul>
        <li>In long term use of haloperidol for schizophrenia and other chronic disorders, daily dose should be reduced to the lowest level possible for maintenance</li>
        <li>In long term use of this medication, routine monitoring including measurement of BMI, BP, fasting blood sugar, and lipid profile is recommended due to risk of side effects</li>
      </ul>
    </section>

    <section>
      <h2>Adverse effects</h2>
      <ul>
        <li>Extrapyramidal symptoms (movement disorders): those are more common than with use of other antipsychotics</li>
        <li>Acute dystonia: muscle spasm develops within hours to days after initiation</li>
        <li>Akathisia: restlessness develops days to months after initiation</li>
        <li>Tardive dyskinesia: uncontrollable repetitive movements develops after years of initiation</li>
        <li>Neuroleptic malignant syndrome</li>
        <li>Muscle rigidity</li>
        <li>Hyperthermia</li>
        <li>Autonomic disturbance</li>
        <li>Anticholinergic side effects: elevated temperature, dry mouth, sedation, constipation and urinary retention</li>
        <li>Weight gain</li>
        <li>Hyperprolactinemia which lead to erectile dysfunction in males, amenorrhea, galactorrhea in females</li>
        <li>It also block alpha adrenergic receptors to some degree leading to postural hypotension, reflex tachycardia and palpitation</li>
        <li>Eye Lens opacities if haloperidol used for long time , because it accumulates in the lens</li>
        <li>QT interval prolongation =&gt; torsades de pointes</li>
      </ul>
    </section>

    <section>
      <h2>Contraindications</h2>
      <ul>
        <li>Previous hypersensitivity reaction in the individual</li>
        <li>Parkinsonâ€™s disease</li>
        <li>Lewy body dementia</li>
        <li>CNS depression, coma patients, concurrent use with barbiturates, benzodiazepines and opioids</li>
      </ul>
    </section>

    <section>
      <h2>Warning</h2>
      <ul>
        <li>There is increased risk of death if haloperidol is used in elderly patient with dementia related psychosis, that is why it is not FDA approved for this use</li>
        <li>IV use with higher doses may lead to torsades de pointes arrhythmia and sudden death</li>
        <li>Motor instability, orthostatic hypotension may lead to falls and fractures while on this medication</li>
      </ul>
    </section>

    <section>
      <h2>Haloperidol toxicity</h2>
      <ul>
        <li>Symptoms of toxicity include</li>
        <ul>
          <li>Severe extrapyramidal symptoms</li>
          <li>Hypotension</li>
          <li>Sedation</li>
          <li>Coma with severe respiratory depression</li>
        </ul>
        <li>There is no antidote for Haloperidol and treatment is supportive</li>
        <li>Gastric lavage and activated charcoal</li>
        <li>ABCs, endotracheal intubation and ventilation</li>
        <li>IV fluids, albumin and vasopressors</li>
      </ul>
    </section>

    <section>
      <h2>Drug Interactions</h2>
      <ul>
        <li>Amiodarone: both prolong QT interval =&gt; torsades de points</li>
        <li>Amphetamine and methylphnidate: haloperidol antagonize the action of norepinephrine and dopamine in patients taking these medications</li>
        <li>Epinephrine: haloperidol antagonize eipinephrine leading to decrease BP</li>
        <li>Levodopa: antagonize</li>
        <li>Lithium: rare cases of encephalopathy if these medications used together</li>
        <li>Methyldopa: increased extrapyramidal side effects</li>
        <li>CYP inducers and inhibitors affect metabolism of haloperidol: inducers such as carbamazepine , phenobarbital and rifampicin associated with low levels of haloperidol, inhibitors such as quinidine, buspirone and fluoxetine associated with higher plasma levels of haloperidol</li>
        <li>Tricyclic antidepressant metabolism decreases if used with haloperidol together and this might lead to toxicity</li>
      </ul>
    </section>
  </main>

  <footer>
    <p>&copy; 2025 Dr M. All Rights Reserved.</p>
  </footer>

</body>
</html>